关注
Maria Jesús Pineda Palacios
Maria Jesús Pineda Palacios
在 usil.pe 的电子邮件经过验证
标题
引用次数
引用次数
年份
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ...
Nature communications 12 (1), 3417, 2021
2072021
Influence of HIV infection on the natural history of hepatocellular carcinoma: results from a global multicohort study
DJ Pinato, E Allara, TY Chen, F Trevisani, B Minguez, M Zoli, M Harris, ...
Journal of Clinical Oncology 37 (4), 296-304, 2019
492019
Retreatment of hepatitis C virus-infected patients with direct-acting antiviral failures
JM Pawlotsky
Seminars in Liver Disease 39 (03), 354-368, 2019
442019
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
AYM Howe, C Rodrigo, EB Cunningham, MW Douglas, J Dietz, J Grebely, ...
JHEP Reports 4 (5), 100462, 2022
372022
Serological and molecular survey of hepatitis E virus in cats and dogs in Spain
J Caballero‐Gómez, A Rivero‐Juarez, E Jurado‐Tarifa, D Jiménez‐Martín, ...
Transboundary and Emerging Diseases 69 (2), 240-248, 2022
342022
Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV
A Corma-Gómez, M Fernández-Fuertes, E García, A Fuentes-López, ...
Clinical Microbiology and Infection 28 (11), 1492-1498, 2022
332022
COVID‐19 in hospitalized HIV‐positive and HIV‐negative patients: A matched study
C Díez, J Del Romero‐Raposo, R Mican, JC López, JR Blanco, ...
HIV medicine 22 (9), 867-876, 2021
332021
Development and Clinical Validation of a Pangenotypic PCR-Based Assay for the Detection and Quantification of Hepatitis E Virus (Orthohepevirus A Genus)
M Frías, P López-López, I Zafra, J Caballero-Gómez, I Machuca, ...
Journal of Clinical Microbiology 59 (2), 10.1128/jcm. 02075-20, 2021
332021
Protist enteroparasites in wild boar (Sus scrofa ferus) and black Iberian pig (Sus scrofa domesticus) in southern Spain: a protective effect on hepatitis E acquisition?
A Rivero-Juarez, A Dashti, P López-López, AS Muadica, MA Risalde, ...
Parasites & Vectors 13, 1-9, 2020
322020
Changes in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV‐infected patients
J Macías, LM Real, A Rivero‐Juarez, N Merchante, A Camacho, ...
HIV medicine 17 (10), 766-773, 2016
322016
Emergent subtype of hepatitis E virus genotype 3 in wild boar in Spain
J Caballero‐Gómez, S Jiménez‐Ruiz, P Lopez‐Lopez, J Vicente, ...
Transboundary and emerging diseases 66 (5), 1803-1808, 2019
302019
Human immunodeficiency virus/hepatits C virus coinfection in Spain: elimination is feasible, but the burden of residual cirrhosis will be significant
J Berenguer, I Jarrín, L Pérez-Latorre, V Hontañón, MJ Vivancos, ...
Open forum infectious diseases 5 (1), ofx258, 2018
302018
Endoplasmic reticulum aminopeptidase 2 haplotypes play a role in modulating susceptibility to HIV infection
M Biasin, M Sironi, I Saulle, M de Luca, F la Rosa, R Cagliani, D Forni, ...
Aids 27 (11), 1697-1706, 2013
302013
Early use of sarilumab in patients hospitalized with COVID-19 pneumonia and features of systemic inflammation: the SARICOR randomized clinical trial
N Merchante, S Cárcel, JC Garrido-Gracia, M Trigo-Rodríguez, ...
Antimicrobial Agents and Chemotherapy 66 (2), e02107-21, 2022
292022
Non-alcoholic fatty liver disease in HIV Infection.
J Macias, JA Pineda, LM Real
AIDS reviews 19 (1), 2017
292017
Evolutionary Analysis Identifies an MX2 Haplotype Associated with Natural Resistance to HIV-1 Infection
M Sironi, M Biasin, R Cagliani, F Gnudi, I Saulle, S Ibba, G Filippi, ...
Molecular biology and evolution 31 (9), 2402-2414, 2014
292014
Low incidence of severe liver toxicity in patients receiving antiretroviral combinations including atazanavir
JA Pineda, R Palacios, A Rivero, L Abdel-kader, M Márquez, P Cano, ...
Journal of Antimicrobial Chemotherapy 57 (5), 1016-1017, 2006
292006
Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ …
E Bouza, JM Aguado, L Alcalá, B Almirante, P Alonso-Fernández, ...
Revista Española de Quimioterapia 33 (2), 151, 2020
282020
Magnitud de la infección por VIH, poblaciones vulnerables y barreras de acceso a la atención sanitaria
MM Arribas, A Rivero, E Fernández, T Poveda, JA Caylá
Enfermedades Infecciosas y Microbiología Clínica 36, 3-9, 2018
282018
Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries
H Leblebicioglu, JE Arends, R Ozaras, G Corti, L Santos, C Boesecke, ...
Antiviral research 150, 9-14, 2018
282018
系统目前无法执行此操作,请稍后再试。
文章 1–20